Wanglong Deng

723 total citations
29 papers, 347 citations indexed

About

Wanglong Deng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wanglong Deng has authored 29 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Wanglong Deng's work include Ferroptosis and cancer prognosis (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Wanglong Deng is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Wanglong Deng collaborates with scholars based in China and United States. Wanglong Deng's co-authors include Yang Liu, Chengde Wang, Yanqin Huang, Chenhan Zhong, Chenglin Liu, Jinghong Xu, Lizhen Zhu, Xuefeng Fang, Dong Xu and Ying Yuan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Wanglong Deng

24 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanglong Deng China 9 136 119 110 86 49 29 347
Chiara Pesenti Italy 14 175 1.3× 130 1.1× 105 1.0× 58 0.7× 26 0.5× 24 405
Cristina Niccoli Italy 11 156 1.1× 129 1.1× 150 1.4× 46 0.5× 72 1.5× 19 393
Daniel Kerr United States 8 231 1.7× 204 1.7× 171 1.6× 47 0.5× 29 0.6× 16 439
Kai Ren Ong United Kingdom 7 150 1.1× 167 1.4× 62 0.6× 28 0.3× 55 1.1× 10 351
Jürgen Stahl Australia 10 216 1.6× 75 0.6× 87 0.8× 40 0.5× 35 0.7× 20 364
Yang Bao China 10 175 1.3× 81 0.7× 86 0.8× 28 0.3× 45 0.9× 22 308
A. Valent France 10 101 0.7× 89 0.7× 155 1.4× 52 0.6× 29 0.6× 18 318
Michal Vočka Czechia 11 144 1.1× 98 0.8× 141 1.3× 50 0.6× 32 0.7× 56 349
Choong Chin Liew United States 8 355 2.6× 81 0.7× 137 1.2× 67 0.8× 39 0.8× 11 590
Leighton C. Stein United States 10 207 1.5× 111 0.9× 132 1.2× 27 0.3× 29 0.6× 18 397

Countries citing papers authored by Wanglong Deng

Since Specialization
Citations

This map shows the geographic impact of Wanglong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanglong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanglong Deng more than expected).

Fields of papers citing papers by Wanglong Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanglong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanglong Deng. The network helps show where Wanglong Deng may publish in the future.

Co-authorship network of co-authors of Wanglong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Wanglong Deng. A scholar is included among the top collaborators of Wanglong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanglong Deng. Wanglong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Bing, Zhiyao Bao, Wei Chen, et al.. (2025). Targeted Next-Generation Sequencing in Pneumonia: Applications in the Detection of Responsible Pathogens, Antimicrobial Resistance, and Virulence. Infection and Drug Resistance. Volume 18. 407–418. 2 indexed citations
2.
Li, Pei, Jianbo Jia, Wanglong Deng, et al.. (2024). Clinical application of targeted next-generation sequencing utilizing bronchoalveolar lavage fluid in thoracic surgery ICU patients with suspected pulmonary infections. Journal of Applied Microbiology. 136(1). 1 indexed citations
3.
Zhao, Yang, Jianwei Liu, Feng Xue, et al.. (2023). Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Annals of Hepatology. 28(2). 100898–100898. 3 indexed citations
4.
Wang, Jian-Gong, Tiantian Han, Mengjuan Wang, et al.. (2023). Mutational landscape of intracranial germ cell tumors.. Journal of Clinical Oncology. 41(16_suppl). e14060–e14060. 1 indexed citations
5.
Zhuang, Dongxiao, et al.. (2023). Prevalence and characteristics analysis of CDKN2A/B deletion in glioma.. Journal of Clinical Oncology. 41(16_suppl). e14026–e14026.
6.
Hu, Wanming, Li Yuan, Xinke Zhang, et al.. (2022). Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma. Cancer Science. 113(5). 1843–1854. 5 indexed citations
7.
Chen, Haibin, Liqing Zhang, Dongsheng Chen, et al.. (2022). NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer. Frontiers in Immunology. 13. 920253–920253. 8 indexed citations
8.
Xu, Fan, et al.. (2022). Molecular characteristics of ERBB2-activating mutations in Chinese patients with NSCLC.. Journal of Clinical Oncology. 40(16_suppl). 8546–8546. 1 indexed citations
9.
Wu, Xiaobing, Tiantian Han, Juan Ma, et al.. (2022). NGS analysis of germline mutation profile of patients with hepatocellular carcinoma in China.. Journal of Clinical Oncology. 40(16_suppl). 10585–10585. 1 indexed citations
10.
Liu, Yifei, Fei Quan, Siqi Chen, et al.. (2022). Correlation between PD-L1 high-expression and EGFR variants in non-small cell lung cancer.. Journal of Clinical Oncology. 40(16_suppl). e21062–e21062. 1 indexed citations
11.
Ma, Juan, et al.. (2021). Molecular characteristics of EGFR exon 19 deletion subtypes in NSCLC patients.. Journal of Clinical Oncology. 39(15_suppl). 8530–8530. 3 indexed citations
12.
Deng, Wanglong, et al.. (2020). General mechanism of JQ1 in inhibiting various types of cancer. Molecular Medicine Reports. 21(3). 1021–1034. 45 indexed citations
13.
14.
Qiu, Zilong, Yue Xiong, Xiaohui Wu, et al.. (2020). L2hgdh Deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration. UNC Libraries. 1 indexed citations
15.
Luo, Qun, et al.. (2018). BRD4 interacts with PML/RARα in acute promyelocytic leukemia. Frontiers of Medicine. 12(6). 726–734. 3 indexed citations
16.
Zhu, Lizhen, Yanqin Huang, Xuefeng Fang, et al.. (2017). A Novel and Reliable Method to Detect Microsatellite Instability in Colorectal Cancer by Next-Generation Sequencing. Journal of Molecular Diagnostics. 20(2). 225–231. 94 indexed citations
17.
Zhang, Fang, et al.. (2017). Regulatory mechanism and functional analysis of S100A9 in acute promyelocytic leukemia cells. Frontiers of Medicine. 11(1). 87–96. 11 indexed citations
18.
Wu, Kang, Ka‐Wing Wong, Wanglong Deng, et al.. (2017). The Numerical Predominance and Large Transcriptome Differences of Neutrophils in Peripheral Blood Together Inevitably Account for a Reported Pulmonary Tuberculosis Signature. International Journal of Genomics. 2017. 1–8. 3 indexed citations
19.
Ma, Shenghong, Bowen Jiang, Wanglong Deng, et al.. (2015). D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth. Oncotarget. 6(11). 8606–8620. 42 indexed citations
20.
Shi, Dongyan, Rui Meng, Wanglong Deng, et al.. (2010). Effects of Microgravity Modeled by Large Gradient High Magnetic Field on the Osteogenic Initiation of Human Mesenchymal Stem Cells. Stem Cell Reviews and Reports. 6(4). 567–578. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Pesenti Breakdown of academic impact, for papers by Cristina Niccoli Breakdown of academic impact, for papers by Daniel Kerr Breakdown of academic impact, for papers by Kai Ren Ong Breakdown of academic impact, for papers by Jürgen Stahl Breakdown of academic impact, for papers by Yang Bao Breakdown of academic impact, for papers by A. Valent Breakdown of academic impact, for papers by Michal Vočka Breakdown of academic impact, for papers by Choong Chin Liew Breakdown of academic impact, for papers by Leighton C. Stein
Rankless by CCL
2026